First National Trust Co acquired a new position in The Allstate Co. (NYSE:ALL – Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 1,468 shares of the insurance provider’s stock, valued at approximately $205,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Ifrah Financial Services Inc. bought a new stake in shares of Allstate in the 4th quarter worth about $204,000. Legacy Financial Advisors Inc. grew its position in shares of Allstate by 2.8% in the 4th quarter. Legacy Financial Advisors Inc. now owns 3,367 shares of the insurance provider’s stock worth $471,000 after acquiring an additional 91 shares in the last quarter. Axxcess Wealth Management LLC bought a new stake in shares of Allstate in the 4th quarter valued at approximately $286,000. Sapient Capital LLC bought a new position in Allstate during the fourth quarter worth $701,000. Finally, Merit Financial Group LLC acquired a new position in Allstate in the fourth quarter worth $259,000. Institutional investors and hedge funds own 76.47% of the company’s stock.
Insider Buying and Selling
In related news, insider John E. Dugenske sold 31,000 shares of the stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total value of $5,276,200.00. Following the completion of the transaction, the insider now owns 63,731 shares of the company’s stock, valued at $10,847,016.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider John E. Dugenske sold 31,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the completion of the sale, the insider now owns 63,731 shares of the company’s stock, valued at $10,847,016.20. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CAO John C. Pintozzi sold 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total transaction of $637,880.00. Following the sale, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The disclosure for this sale can be found here. Company insiders own 1.80% of the company’s stock.
Allstate Stock Up 0.7 %
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings results on Thursday, May 2nd. The insurance provider reported $5.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.11 by $1.02. Allstate had a net margin of 2.31% and a return on equity of 14.44%. The company had revenue of $15.26 billion during the quarter, compared to analysts’ expectations of $12.76 billion. During the same period in the prior year, the company earned ($1.30) earnings per share. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. Equities research analysts predict that The Allstate Co. will post 14.57 EPS for the current year.
Allstate Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, April 1st. Investors of record on Monday, March 4th were given a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 2.17%. The ex-dividend date of this dividend was Friday, March 1st. This is a positive change from Allstate’s previous quarterly dividend of $0.89. Allstate’s dividend payout ratio is 81.24%.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on ALL shares. Piper Sandler upped their target price on Allstate from $172.00 to $188.00 and gave the company an “overweight” rating in a report on Monday, April 1st. UBS Group raised their price target on Allstate from $171.00 to $185.00 and gave the company a “buy” rating in a report on Monday, February 12th. TheStreet raised shares of Allstate from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. BMO Capital Markets upped their target price on Allstate from $140.00 to $158.00 and gave the stock a “market perform” rating in a research report on Friday, January 19th. Finally, Keefe, Bruyette & Woods upped their price objective on Allstate from $181.00 to $189.00 and gave the company an “outperform” rating in a report on Wednesday, April 10th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $174.18.
View Our Latest Analysis on Allstate
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- Dividend Payout Ratio Calculator
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Value Stocks You Can Buy Before They Become Big
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.